Mesoblast (MESO) EBITDA (2014 - 2023)
Mesoblast (MESO) reported EBITDA of $267.02 million for the year ended Jun 30, 2026, up 188.4% from $92.58 million a year earlier.
Powered by 
Analysis
Mesoblast (MESO) EBITDA (2014 - 2023) Analysis & Trends
Dating back to the year ended Jun 30, 2015, Mesoblast's EBITDA record includes 12 years.
- The figure for the year ended Jun 30, 2026 ranks as the highest annual EBITDA in data going back to the year ended Jun 30, 2015.
- According to Business Quant data, EBITDA came in at $92.58 million in the year ended Jun 30, 2025 (+23.0%), $75.26 million in the year ended Jun 30, 2024 (-18.1%), $91.9 million in the year ended Jun 30, 2023 and -$104.49 million in the year ended Jun 30, 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,143.62 Bn | 1,112.20 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 635.32 Bn | 555.18 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 501.71 Bn | 474.82 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 356.04 Bn | 310.42 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 300.80 Bn | 264.79 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 263.31 Bn | 237.00 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 238.70 Bn | 194.10 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 194.80 Bn | 169.00 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 170.88 Bn | 117.53 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Mesoblast | 1.59 Bn | 1.16 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | -16.58 Mn |
| Mar 31, 2023 | -12.67 Mn |
| Dec 31, 2022 | -17.28 Mn |
| Sep 30, 2022 | -11.28 Mn |
| Jun 30, 2022 | -16.10 Mn |
| Mar 31, 2022 | -16.32 Mn |
| Dec 31, 2021 | -19.54 Mn |
| Sep 30, 2021 | -17.47 Mn |
| Jun 30, 2021 | -22.15 Mn |
| Mar 31, 2021 | -21.58 Mn |
| Dec 31, 2020 | -20.58 Mn |
| Sep 30, 2020 | -20.34 Mn |
| Jun 30, 2020 | -31.06 Mn |
| Mar 31, 2020 | -12.54 Mn |
| Dec 31, 2019 | -22.39 Mn |
| Sep 30, 2019 | -2.99 Mn |
| Jun 30, 2019 | -19.60 Mn |
| Mar 31, 2019 | -23.50 Mn |
| Dec 31, 2018 | -24.44 Mn |
| Sep 30, 2018 | -17.00 Mn |
API Access
Mesoblast EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=MESO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "MESO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=MESO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();